leisure time -WSS

leisure time

author：knowledge 2025-10-01 06:01:34 - browse：6478

Are biotech’s dog days over? What’s a PIPE? And what can unseat Wegovy?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We dive into the the latest craze in the world of biotech finance, involving hedge funds and some insider information, and explain why not everyone thinks it’s such a good idea. We also discuss a banner month for biotech stocks and the latest twist in obesity research.

For more on what we cover, here’s more on PIPEs; here’s the news from Viking Therapeutics; here’s the latest in MASH; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Drug repurposing or repositioning? The language matters
Next article： As pharma fights Medicare drug negotiation, hospitals, docs silent

entertainment

WSS

Warren pushes Witty on UnitedHealth's control over physicians

BIO to announce reorganization, senior leaders expected to depart

Complete sequence of Y chromosome published for first time

The creative science of coining drug names

FDA panel gives mixed vote on blood pressure devices

How to make Best Hospitals ratings actually useful for patients

leisure time

leisure time

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

As pharma fights Medicare drug negotiation, hospitals, docs silent

Peter Hotez and the public health issue of online harassment

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Malaria cases in Florida and Texas: Here’s what you need to know

Australia’s approach to dialysis celebrates life

Psychedelics group wrestles with new pharma identity

Sepsis can kill a child within hours. Here's how hospitals are fighting back

BioMarin wins approval for gene therapy to treat hemophilia A

Psilocybin's anti

focus

Australia’s approach to dialysis celebrates life

The effects of a landmark ruling on DNA ownership are becoming clearer

How Long Island became the ‘eugenics capital of the world’

PBM executives asked to testify by House panel

FDA panel gives mixed vote on blood pressure devices

Why more medical students aren't specializing in primary care

hotspot

entertainment

Wikipedia

focus